Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort
| Autor: | Smith, Matthew R., Antonarakis, Emmanuel S., Ryan, Charles J., Berry, William R., Shore, Neal D., Liu, Glenn, Alumkal, Joshi J., Higano, Celestia S., Chow Maneval, Edna, Bandekar, Rajesh, de Boer, Carla J., Yu, Margaret K., Rathkopf, Dana E. |
|---|---|
| Zdroj: | In European Urology December 2016 70(6):963-970 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect